雙源CT灌注成像在肝轉(zhuǎn)移瘤中的臨床應(yīng)用
[Abstract]:Objective: to evaluate the clinical value of dual-source CT perfusion imaging in the diagnosis and treatment of hepatic metastasis. Methods: the whole liver CT perfusion was performed with dual-source CT. The blood flow (BF), blood volume, (BV), peak time, (TTP), hepatic artery perfusion volume, (ALP), portal vein perfusion volume (PVP), were obtained. The perfusion parameters such as hepatic artery perfusion index (HPI) and perfusions were analyzed statistically. Results: (1) the arterial perfusion volume and arterial perfusion index of hepatic metastases were higher than those of the surrounding liver parenchyma, while the portal vein perfusion decreased and the peak time was shortened. (2) the TDC (time density curve) of hepatic metastatic tumors was significantly changed, while the hepatic arterial perfusion volume and arterial perfusion index were higher than those of the surrounding liver parenchyma. (3) the perfusion images of metastatic tumors were different between the rich blood supply and the lack of blood supply. On the ALP and HPI pseudo-color images, the periphery of the lesion showed high perfusion, and the peak value appeared earlier. (3) there was a certain difference in the perfusion pattern between the rich blood supply and the lack of blood supply in the peripheral part of the lesion. There were low perfusion in the center of the metastatic tumor with low blood supply, uneven and high perfusion in the center of the metastatic tumor with rich blood supply, and slightly lower perfusion in the surrounding liver parenchyma. On the PVP images, the tumor focus showed low perfusion and the surrounding liver parenchyma showed high perfusion. (4) the lesion area in HPI and ALP perfusions was larger than that in CT enhanced images. Conclusion: dual-source CT perfusion can reflect the blood supply of hepatic metastatic tumor, and it is of great significance to evaluate the true size of the tumor, preoperative guidance and postoperative evaluation of the metastatic tumor.
【作者單位】: 濱州醫(yī)學(xué)院附屬醫(yī)院;
【分類號】:R735.7
【參考文獻】
相關(guān)期刊論文 前4條
1 李敏達;李敏;顧紅梅;曹亮;周康榮;周建軍;;MSCT灌注成像在肝臟常見腫瘤鑒別診斷中的臨床應(yīng)用價值[J];臨床放射學(xué)雜志;2012年03期
2 王守安;白人駒;孫浩然;征錦;;肝轉(zhuǎn)移瘤的CT灌注成像[J];實用放射學(xué)雜志;2007年09期
3 朱紅洲;;肝臟腫瘤的MR彌散加權(quán)成像和CT灌注成像的比較[J];實用醫(yī)學(xué)雜志;2009年08期
4 蘇佰燕;金征宇;劉煒;孫昊;王萱;陳鈺;薛華丹;張云慶;徐凱;;第二代雙源CT對肝臟八段灌注成像的特點[J];中國醫(yī)學(xué)科學(xué)院學(xué)報;2010年06期
【共引文獻】
相關(guān)期刊論文 前10條
1 倪明;呂維富;鄧克學(xué);周春澤;丁作鵬;;多層螺旋CT灌注成像在肝轉(zhuǎn)移瘤中的應(yīng)用[J];安徽醫(yī)藥;2012年06期
2 孫勝杰;李鳳琪;錢海峰;;MRI-DTI成像DTT技術(shù)及FA值對腦膜瘤術(shù)前的指導(dǎo)和術(shù)后的評價作用[J];浙江中醫(yī)藥大學(xué)學(xué)報;2012年06期
3 黃淵全;馮耀良;;肝臟CT灌注成像及其臨床應(yīng)用[J];中國CT和MRI雜志;2008年05期
4 古杰洪;黃云海;郭永梅;丁漢軍;;320排CT全肝灌注成像臨床應(yīng)用初探[J];中國CT和MRI雜志;2012年02期
5 薛敏娜;白人駒;李豐坦;付俊杰;張翔;孫孟瑞;;CT灌注成像對原發(fā)性肝癌、肝轉(zhuǎn)移瘤和肝血管瘤的鑒別診斷價值[J];國際醫(yī)學(xué)放射學(xué)雜志;2008年03期
6 金觀橋;蘇丹柯;謝東;劉麗東;李強;張昱平;黃偉麗;蒙金鳳;;多層螺旋CT各向同性成像對鼻咽癌T分期的應(yīng)用價值[J];廣西醫(yī)科大學(xué)學(xué)報;2008年06期
7 袁家長;陳廣穎;李亮;邵平;;腦血管狹窄的CTA診斷價值(附52例分析)[J];安徽醫(yī)學(xué);2012年08期
8 任金武;張立紅;陳為軍;王藏海;牛艷坤;;CT灌注成像診斷肝臟占位性病變的研究現(xiàn)狀[J];華北國防醫(yī)藥;2010年06期
9 趙周社;辛軍;郭啟勇;王爽;陸U,
本文編號:2437055
本文鏈接:http://sikaile.net/yixuelunwen/fangshe/2437055.html